NITRO: A randomised phase 3 trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1065856

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Preliminary studies suggest that nitroglycerin paste can substantially improve the results of chemotherapy for advanced lung cancer. NITRO is a definitive, large-scale, randomised trial that is needed to reliably determine if these promising results are true, and worthy of widespread application in routine clinical practice.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $504,960.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer chemotherapy | lung cancer | nitroglycerin | randomised controlled trial (RCT) | survival

Related Links